NIH-funded research U01 cooperative agreement

Investigating frailty and aging in childhood cancer survivors

Official title: Sen-Survivors: An open-label intervention trial for frailty and senescence

Funded at St. Jude Children's Research Hospital · NIH-9890475 · Data updated 2026-11-12

This study is looking at childhood cancer survivors to see how they might face health challenges similar to older adults as they grow up, and it aims to find ways to help them stay strong and healthy by exploring treatments that could improve their well-being.

More Frailty research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startSeptember 1, 2020
Project endAugust 31, 2025
Funding year2020
Award (this year)$2,277,711
NIH project number1U01CA246510-01
Project IDNIH-9890475 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are survivors of childhood cancer and may be experiencing signs of frailty.

Less likely to help

Patients who are not childhood cancer survivors or those who do not exhibit signs of frailty may not benefit from this research.

What this research studies

This research focuses on childhood cancer survivors who may experience early onset frailty and aging-related health issues as they reach adulthood. It aims to identify the physiological changes associated with frailty, such as low muscle mass and reduced strength, which are typically seen in older adults. The study will explore the role of cellular senescence, a process linked to aging, and how it may be targeted to improve health outcomes in these survivors. Participants may receive interventions involving specific agents that could help mitigate the effects of frailty and promote healthier aging.

Why it matters

Potential benefit: If successful, this research could lead to improved health interventions for childhood cancer survivors, enhancing their quality of life as they age.

How similar studies have gone: Previous research has shown promising results in targeting cellular senescence to improve health outcomes in aging populations, suggesting potential for success in this novel approach.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Armstrong, Gregory — St. Jude Children's Research Hospital
  • Study coordinator: Armstrong, Gregory

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.